Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Ranbaxy Pharmaceuticals (Pty) Ltd, 14 Lautre Road, Stormill Ext.1, Roodepoort, 1724, South Africa
PAINAMOL PLUS.
| Pharmaceutical Form |
|---|
|
Tablet. Flat yellow and red mottled tablet, scored on the one side and a “b” embossed on the other side. |
Each tablet contains:
Paracetamol 500 mg.
Codeine Phosphate 8 mg.
Preservative:
Sodium metabisulphite 0,081% m/m
Contains TARTRAZINE.
Contains sugar: sucrose 20,0 mg per tablet.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Codeine |
Codeine is a centrally acting weak analgesic. Codeine exerts its effect through μ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain. The anti-tussive activity of codeine is probably due to its depressant effect on the medullary cough centre in the brain. |
|
| Paracetamol |
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
| List of Excipients |
|---|
|
Alcohol 90% v/v |
Cartons with 2 X 10 tablets in push through blister packs.
Containers with 100, 500 and 1000 tablets.
Blue/green plastic buckets containing 5000 tablets.
Patient ready packs of different pack sizes.
Ranbaxy Pharmaceuticals (Pty) Ltd, 14 Lautre Road, Stormill Ext.1, Roodepoort, 1724, South Africa
P/2.8/311 (S.A.)
27 February 1996
| Drug | Countries | |
|---|---|---|
| PAINAMOL PLUS | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
